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Older adults are susceptible to severe coronavirus disease 
2019 (COVID-19) outcomes as a consequence of their age and, 
in some cases, underlying health conditions (1). A COVID-19 
outbreak in a long-term care skilled nursing facility (SNF) 
in King County, Washington that was first identified on 
February 28, 2020, highlighted the potential for rapid spread 
among residents of these types of facilities (2). On March 1, 
a health care provider at a second long-term care skilled nursing 
facility (facility A) in King County, Washington, had a positive 
test result for SARS-CoV-2, the novel coronavirus that causes 
COVID-19, after working while symptomatic on February 26 
and 28. By March 6, seven residents of this second facility were 
symptomatic and had positive test results for SARS-CoV-2. 
On March 13, CDC performed symptom assessments and 
SARS-CoV-2 testing for 76 (93%) of the 82 facility A residents 
to evaluate the utility of symptom screening for identification 
of COVID-19 in SNF residents. Residents were categorized as 
asymptomatic or symptomatic at the time of testing, based on 
the absence or presence of fever, cough, shortness of breath, or 
other symptoms on the day of testing or during the preceding 
14 days. Among 23 (30%) residents with positive test results, 
10 (43%) had symptoms on the date of testing, and 13 (57%) 
were asymptomatic. Seven days after testing, 10 of these 13 
previously asymptomatic residents had developed symptoms 
and were recategorized as presymptomatic at the time of 
testing. The reverse transcription–polymerase chain reaction 
(RT-PCR) testing cycle threshold (Ct) values indicated large 
quantities of viral RNA in asymptomatic, presymptomatic, 
and symptomatic residents, suggesting the potential for trans-
mission regardless of symptoms. Symptom-based screening 
in SNFs could fail to identify approximately half of residents 
with COVID-19. Long-term care facilities should take proac-
tive steps to prevent introduction of SARS-CoV-2 (3). Once 
a confirmed case is identified in an SNF, all residents should 
be placed on isolation precautions if possible (3), with con-
siderations for extended use or reuse of personal protective 
equipment (PPE) as needed (4).
Immediately upon identification of the index case in 
facility A on March 1, nursing and administrative leader-
ship instituted visitor restrictions, twice-daily assessments of 
COVID-19 signs and symptoms among residents, and fever 
screening of all health care personnel at the start of each shift. 
On March 6, Public Health – Seattle and King County, in 
collaboration with CDC, recommended infection prevention 
and control measures, including isolation of all symptomatic 
residents and use of gowns, gloves, eye protection, facemasks, 
and hand hygiene for health care personnel entering symptom-
atic residents’ rooms. A data collection tool was developed to 
ascertain symptom status and underlying medical conditions 
for all residents.
On March 13, the symptom assessment tool was completed 
by facility A’s nursing staff members by reviewing screening 
records of residents for the preceding 14 days and by clinician 
interview of residents at the time of specimen collection. For 
residents with significant cognitive impairment, symptoms 
were obtained solely from screening records. A follow-up 
symptom assessment was completed 7 days later by nursing 
staff members. Nasopharyngeal swabs were obtained from all 
76 residents who agreed to testing and were present in the 
facility at the time; oropharyngeal swabs were also collected 
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Summary
What is already known about this topic?
Once SARS-CoV-2 is introduced in a long-term care skilled 
nursing facility (SNF), rapid transmission can occur.
What is added by this report?
Following identification of a case of coronavirus disease 2019 
(COVID-19) in a health care worker, 76 of 82 residents of an SNF 
were tested for SARS-CoV-2; 23 (30.3%) had positive test results, 
approximately half of whom were asymptomatic or presymp-
tomatic on the day of testing. 
What are the implications for public health practice?
Symptom-based screening of SNF residents might fail to 
identify all SARS-CoV-2 infections. Asymptomatic and 
presymptomatic SNF residents might contribute to SARS-CoV-2 
transmission. Once a facility has confirmed a COVID-19 case, all 
residents should be cared for using CDC-recommended 
personal protective equipment (PPE), with considerations for 
extended use or reuse of PPE as needed.
from most residents, depending upon their cooperation. 
The Washington State Public Health Laboratory performed 
one-step real-time RT-PCR assay on all specimens using the 
SARS-CoV-2 CDC assay protocol, which determines the 
presence of the virus through identification of two genetic 
markers, the N1 and N2 nucleocapsid protein gene regions 
(5). The Ct, the cycle number during RT-PCR testing when 
detection of viral amplicons occurs, is inversely correlated with 
the amount of RNA present; a Ct value <40 cycles denotes a 
positive result for SARS-CoV-2, with a lower value indicating 
a larger amount of viral RNA.
Residents were assessed for stable chronic symptoms (e.g., 
chronic, unchanged cough) as well as typical and atypical signs 
and symptoms of COVID-19. Typical COVID-19 signs and 
symptoms include fever, cough, and shortness of breath (3); 
potential atypical symptoms assessed included sore throat, 
chills, increased confusion, rhinorrhea or nasal congestion, 
myalgia, dizziness, malaise, headache, nausea, and diarrhea. 
Residents were categorized as asymptomatic (no symptoms or 
only stable chronic symptoms) or symptomatic (at least one 
new or worsened typical or atypical symptom of COVID-19) 
on the day of testing or during the preceding 14 days. Residents 
with positive test results and were asymptomatic at time of 
testing were reevaluated 1 week later to ascertain whether any 
symptoms had developed in the interim. Those who devel-
oped new symptoms were recategorized as presymptomatic. 
Ct values were compared for the recategorized symptom 
groups using one-way analysis of variance (ANOVA) for all 
residents with positive test results for SARS-CoV-2. Analyses 
were conducted using SAS statistical software (version 9.4; 
SAS Institute).
On March 13, among the 82 residents in facility A; 76 
(92.7%) underwent symptom assessment and testing; three 
(3.7%) refused testing, two (2.4%) who had COVID-19 
symptoms were transferred to a hospital before testing, and 
one (1.2%) was unavailable. Among the 76 tested residents, 
23 (30.3%) had positive test results.
Demographic characteristics were similar among the 53 
(69.7%) residents with negative test results and the 23 (30.3%) 
with positive test results (Table 1). Among the 23 residents with 
positive test results, 10 (43.5%) were symptomatic, and 13 
(56.5%) were asymptomatic. Eight symptomatic residents had 
typical COVID-19 symptoms, and two had only atypical symp-
toms; the most common atypical symptoms reported were malaise 
(four residents) and nausea (three). Thirteen (24.5%) residents 
who had negative test results also reported typical and atypical 
COVID-19 symptoms during the 14 days preceding testing.
One week after testing, the 13 residents who had positive test 
results and were asymptomatic on the date of testing were reas-
sessed; 10 had developed symptoms and were recategorized as pre-
symptomatic at the time of testing (Table 2). The most common 
signs and symptoms that developed were fever (eight residents), 
malaise (six), and cough (five). The mean interval from testing 
to symptom onset in the presymptomatic residents was 3 days. 
Three residents with positive test results remained asymptomatic.
Real-time RT-PCR Ct values for both genetic markers 
among residents with positive test results for SARS-CoV-2 
ranged from 18.6 to 29.2 (symptomatic [typical symptoms]), 
24.3 to 26.3 (symptomatic [atypical symptoms only]), 15.3 
to 37.9 (presymptomatic), and 21.9 to 31.0 (asymptomatic) 
(Figure). There were no significant differences between the 
mean Ct values in the four symptom status groups (p = 0.3).
Discussion
Sixteen days after introduction of SARS-CoV-2 into facility A, 
facility-wide testing identified a 30.3% prevalence of infec-
tion among residents, indicating very rapid spread, despite 
early adoption of infection prevention and control measures. 
Approximately half of all residents with positive test results 
did not have any symptoms at the time of testing, suggesting 
that transmission from asymptomatic and presymptomatic 
residents, who were not recognized as having SARS-CoV-2 
infection and therefore not isolated, might have contributed to 
further spread. Similarly, studies have shown that influenza in 
the elderly, including those living in SNFs, often manifests as 
few or atypical symptoms, delaying diagnosis and contributing 
to transmission (6–8). These findings have important implica-
tions for infection control. Current interventions for preventing 
SARS-CoV-2 transmission primarily rely on presence of signs 
and symptoms to identify and isolate residents or patients who 
might have COVID-19. If asymptomatic or presymptomatic 
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residents play an important role in transmission in this popula-
tion at high risk, additional prevention measures merit consid-
eration, including using testing to guide cohorting strategies or 
using transmission-based precautions for all residents of a facility 
after introduction of SARS-CoV-2. Limitations in availability 
of tests might necessitate taking the latter approach at this time.
Although these findings do not quantify the relative con-
tributions of asymptomatic or presymptomatic residents to 
SARS-CoV-2 transmission in facility A, they suggest that these 
residents have the potential for substantial viral shedding. 
Low Ct values, which indicate large quantities of viral RNA, 
were identified for most of these residents, and there was no 
statistically significant difference in distribution of Ct values 
among the symptom status groups. Similar Ct values were 
reported in asymptomatic adults in China who were known to 
transmit SARS-CoV-2 (9). Studies to determine the presence 
of viable virus from these specimens are currently under way.
SNFs have additional infection prevention and control chal-
lenges compared with those of assisted living or independent 
living long-term care facilities. For example, SNF residents might 
be in shared rooms rather than individual apartments, and there 
is often prolonged and close contact between residents and 
TABLE 1. Demographics and reported symptoms for residents of a long-term care skilled nursing facility at time of testing* (N = 76), by 
SARS-CoV-2 test results — facility A, King County, Washington, March 2020
Characteristic
Initial SARS-CoV-2 test results
Negative, no. (%) Positive, no. (%)
Overall 53 (100) 23 (100)
Women 32 (60.4) 16 (69.6)
Age, mean (SD) 75.1 (10.9) 80.7 (8.4)
Current smoker† 7 (13.2) 1 (4.4)
Long-term admission type to facility A 35 (66.0) 15 (65.2)
Length of stay in facility A before test date, days, median (IQR) 94 (40–455) 70 (21–504)
Symptoms in last 14 days
Symptomatic 13 (24.5) 10 (43.5)
At least one typical COVID-19 symptom§ 9 (17.0) 8 (34.8)
Only atypical COVID-19 symptoms¶ 4 (7.5) 2 (8.7)
Asymptomatic 40 (75.5) 13 (56.5)
No symptoms 32 (60.4) 8 (34.8)
Only stable, chronic symptoms 8 (15.1) 5 (21.7)
Specific signs and symptoms reported as new or worse in last 14 days
Typical symptoms
Fever 3 (5.7) 1 (4.3)
Cough 6 (11.3) 7 (30.4)
Shortness of breath 0 (0) 1 (4.4)
Atypical symptoms
Malaise 1 (1.9) 4 (17.4)
Nausea 0 (0) 3 (13.0)
Sore throat 2 (3.8) 2 (8.7)
Confusion 2 (3.8) 1 (4.4)
Dizziness 1 (1.9) 1 (4.4)
Diarrhea 3 (5.7) 1 (4.4)
Rhinorrhea/Congestion 1 (1.9) 0 (0)
Myalgia 0 (0) 0 (0)
Headache 0 (0) 0 (0)
Chills 0 (0) 0 (0)
Any preexisting medical condition listed 53 (100) 22 (95.7)
Specific conditions**
Chronic lung disease 16 (30.2) 10 (43.5)
Diabetes 20 (37.7) 9 (39.1)
Cardiovascular disease 36 (67.9) 20 (87.0)
Cerebrovascular accident 19 (35.9) 8 (34.8)
Renal disease 18 (34.0) 9 (39.1)
Received hemodialysis 2 (3.8) 2 (8.7)
Cognitive Impairment 28 (52.8) 13 (56.5)
Obesity 11 (20.8) 6 (26.1)
Abbreviations: COVID-19 = coronavirus disease 2019; IQR = interquartile range, SD = standard deviation.
 * Testing performed on March 13, 2020.
 † Unknown for one resident with negative test results.
 § Typical symptoms include fever, cough, and shortness of breath.
 ¶ Atypical symptoms include chills, malaise, sore throat, increased confusion, rhinorrhea or nasal congestion, myalgia, dizziness, headache, nausea, and diarrhea.
 ** Residents might have multiple conditions.
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TABLE 2. Follow-up symptom assessment 1 week after testing for 
SARS-CoV-2 among 13 residents of a long-term care skilled nursing 
facility who were asymptomatic on March 13, 2020 (date of testing) 
and had positive test results — facility A, King County, Washington, 
March 2020
Symptom status 1 week after testing No. (%)
Asymptomatic 3 (23.1)
Developed new symptoms 10 (76.7)
Fever 8 (61.5)
Malaise 6 (46.1)
Cough 5 (38.4)
Confusion 4 (30.8)
Rhinorrhea/Congestion 4 (30.8)
Shortness of breath 3 (23.1)
Diarrhea 3 (23.1)
Sore throat 1 (7.7)
Nausea 1 (7.7)
Dizziness 1 (7.7)
health care providers related to the residents’ medical conditions 
and cognitive function. The index patient in this outbreak was 
a health care provider, which might have contributed to rapid 
spread in the facility. In addition, health care personnel in all types 
of long-term care facilities might have limited experience with 
proper use of PPE. Symptom ascertainment and room isolation 
can be exceptionally challenging in elderly residents with neuro-
logic conditions, including dementia. In addition, symptoms of 
COVID-19 are common and might have multiple etiologies in 
this population; 24.5% of facility A residents with negative test 
results for SARS-CoV-2 reported typical or atypical symptoms.
The findings in this report are subject to at least two limita-
tions. First, accurate symptom ascertainment in persons with 
cognitive impairment and other disabilities is challenging; 
however, this limitation is estimated to be representative of 
symptom data collected in most SNFs, and thus, these find-
ings might be generalizable. Second, because this analysis was 
conducted among residents of an SNF, it is not known whether 
findings apply to the general population, including younger 
persons, those without underlying medical conditions, or 
similarly aged populations in the general community.
This analysis suggests that symptom screening could initially 
fail to identify approximately one half of SNF residents with 
SARS-CoV-2 infection. Unrecognized asymptomatic and 
presymptomatic infections might contribute to transmission 
in these settings. During the current COVID-19 pandemic, 
SNFs and all long-term care facilities should take proactive 
steps to prevent introduction of SARS-CoV-2, including 
restricting visitors except in compassionate care situations, 
restricting nonessential personnel from entering the building, 
asking staff members to monitor themselves for fever and other 
symptoms, screening all staff members at the beginning of 
their shift for fever and other symptoms, and supporting staff 
member sick leave, including for those with mild symptoms 
(3). Once a facility has a case of COVID-19, broad strategies 
should be implemented to prevent transmission, including 
restriction of resident-to-resident interactions, universal use 
of facemasks for all health care personnel while in the facility, 
and if possible, use of CDC-recommended PPE for the care of 
all residents (i.e., gown, gloves, eye protection, N95 respirator, 
or, if not available, a face mask) (3). In settings where PPE sup-
plies are limited, strategies for extended PPE use and limited 
reuse should be employed (4). As testing availability improves, 
consideration might be given to test-based strategies for iden-
tifying residents with SARS-CoV-2 infection for the purpose 
of cohorting, either in designated units within a facility or in 
a separate facility designated for residents with COVID-19. 
During the COVID-19 pandemic, collaborative efforts are 
crucial to protecting the most vulnerable populations.
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